Recently, various physiological effects of the tea polyphenol catechin for improving diseases such as cancer, arteriosclerosis, hyperlipedimia, and osteoporosis have been reported. However, the physiological effect of catechin on bone metabolism remains unclear. We examined the physiological effect of (-)-epigallocatechin-3-gallate (EGCG), which is the main component of green tea catechin, on osteoblast development using the precursor cell line of osteoblasts, MC3T3-E1, and co-culture of the osteoblasts from mouse newborn calvaria and mouse bone marrow cells. Although EGCG did not affect the viability and proliferation of MC3T3-E1, EGCG inhibited the osteoblast differentiation. Furthermore, EGCG did not affect the mineralization of differentiated MC3T3-E1, and reduced osteoclast formation in co-culture. These results suggest that EGCG can effectively suppress bone resorption, and can be used as an effective medicine for the symptoms of osteoporosis.
INTRODUCTION
Recently, various physiological effects of the tea polyphenol catechin for improving diseases such as cancer, arteriosclerosis, hyperlipemia, and osteoporosis have been reported (McKay and Blumberg, 2002; Crespy and Williamson, 2004) . Green tea contains catechins such as (-)-epigallocatechin-3-gallate (EGCG),
(-)-epicatechin-3-gallate (ECG), (-)-epicatechin (EC) and (-)-epigallocatechin (EGC),
with EGCG accounting for more than 50% of the total of catechins (Nagle et al., 2006) .
In mammals, EGCG has the effect of improving lifestyle-related diseases such as tumor, allergy and arteriosclerosis (McKay and Blumberg, 2002; Crespy and Williamson, 2004) . EGCG has various physiological functions such as the protection of DNA damage/methylation, suppression of protease activity, induction of apoptosis, and regulation of cell cycle and arrest, in the cell (Khan et al., 2006; Chen et al., 2008) .
Generally, although EGCG has strong anti-oxidant activity, it is difficult to explain the various physiological functions of catechin only by the anti-oxidization activity.
Recently, Tachibana et al. (2004) reported that EGCG acted on a specific signaling pathway through binding to the 67 kDa laminin receptor (67LR).
Tea polyphenol is known to mitigate osteoporosis as one of its physiological roles (Hegarty et al., 2000) . Osteoporosis is caused by, for example, an imbalance of bone metabolism induced by the promotion of bone resorption due to a lack of estrogen during menopause (Saika et al., 2001) . Usually, the amount of bone remains constant, as osteoblast-induced bone formation is balanced by bone resorption by osteoclasts, and the number and function of osteoclasts and osteoblasts are kept normal by the mutual interaction of these cells (Takahashi et al., 1988a; Jimi et al., 1996) . For example, osteoblasts produce the colony stimulating factor-1 (CSF-1) and the differentiation-inducing factor, receptor activator of nuclear factor κB ligand (RANKL), and they act on the precursor of osteoclasts to promote the differentiation of osteoclast (Yoshida et al., 1990; Amano et al., 1998; Lacey et al., 1998; Yasuda et al., 1998) .
Moreover, the activated vitamin D 3 (1, 25(OH) 2 D 3 ), prostaglandin E 2 and the parathyroid hormone act on osteoblasts, and control the differentiation of osteoclasts through the expression of RANKL (Takahashi et al., 1988a; Suda et al., 1999) . On the other hand, osteoblasts differentiate from the mesenchymal stem cell under the stimulation of bone morphogenetic protein (BMP) (Katagiri and Takahashi, 2002) . A mesenchymal stem cell may potentially differentiate into osteoblast, muscle cell or adipocyte. The differentiation of osteoblasts is led by the induction of expression of alkaline phosphatase (ALP) or bone matrix proteins such as type I collagen, osteocalcin (OCN) and osteopontin, under the action of the transcription factors runt-related transcription factor 2 (Runx2) and Osterix (Nakashima et al., 2002; Komori, 2005) .
Furthermore, the repression of the differentiation factor to muscle cell and adipocyte also leads to the differentiation to osteoblasts (Nakashima et al., 2002; Komori, 2005) .
To date, little has been known about the physiological role of EGCG, except the induction of osteoclast cell death (Nakagawa et al., 2002; Yun et al., 2007) and mineralization of osteoblasts (Takita et al., 2002; Vali et al., 2007) . This report aims to elucidate the physiological role and molecular mechanism of tea catechin on bone metabolism.
MATERIALS AND METHODS

Expression plasmid
The expression plasmid (pGEX-2TK-RANKL) for the soluble RANKL-GST fusion protein was a gift from Dr. Takeya at the University of Nara Institute of Science and
Technology (Meiyanto et al., 2001; Ishida et al., 2002) . (Chang et al., 2003) . Cells were washed with distilled water and observed under an optical microscope.
Cell culture
ALP activity assay
After the culture, cells were washed with PBS. The enzyme activity of ALP was measured by directly adding 100 µL/well of ALP-assay-buffer (0.6 M diethanolamine, 0.6 mM MgCl 2 , 0.1% Triton X-100, and 30 mM p-nitrophenylphosphate) to each well.
After the incubation for 15 min at room temperature, the reaction was terminated by adding 50 µL/well of 3 M NaOH, and the absorbance was measured at 405 nm using microplate reader (Kodaira et al., 2006 Cell viability was determined by 3-(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay. MC3T3-E1 cells were plated on a 96-well plate at 2 × 10 3 cells/well and cultured for 48 h. Then, the culture medium was replaced with new medium containing EGCG and cultured for additional 48 h. After the culture, cells were washed with PBS, MTT was added and incubated for additional 3 h. The product was dissolved in 0.04 N HCl in isopropanol, and the absorbance at 570 nm was measured.
Cell proliferation was analyzed by using BrdU Cell Proliferation Assay Kit (Merck, Whitehouse Station, NJ, USA). MC3T3-E1 cells were cultured with EGCG for 24 h. Then, cells were incubated with BrdU for additional 6 h, and the absorbance at 450-540 nm was measured.
PCR analysis
Cells were cultured on 40-mm dishes, and the total RNA was extracted by a standard acid-GTC-phenol extraction method (Chomczynski and Sacchi, 1987) . The cDNA was synthesized by M-MLV Reverse Transcriptase (Takara Bio, Otsu, Shiga, Japan), and subjected for PCR using the following primers:
G3PDH primers:
Osteocalcin (OCN) primers:
Alkaline phosphatase (ALP) primers:
Receptor activator of nuclear factor κB ligand (RANKL) primers:
Colony stimulating factor-1 (CSF-1) primers:
PCR was performed using following conditions; for G3PDH primers ( 
Mineralization assay
MC3T3-E1 cells were cultured for 10 d. Then, the culture medium was replaced with new medium containing 10 mM β-glycerophosphate and cultured for additional 10 d. After the culture, cells were washed with PBS, and fixed with 70% EtOH for 1 h at room temperature. Cells were washed with distilled water, and 100 µL of 1% Alizarin
Red S solution (Kanto Chemical Co., Inc.) was added to each well and incubated. After 30 min incubation, cells were washed with distilled water. Then, the dye was dissolved in 100 µL of 100 mM cetylpyridinium, and absorbance was measured at 562 nm (Wang et al., 2007) .
TRAP staining
Cells were washed with PBS, and cells were fixed by incubation with 100 µL of 4% paraformaldehyde at 4 °C for 1 h. (Matsumoto et al., 2000) . Cells were washed with water and observed under an optical microscope.
Statistical analysis
Results are expressed as mean ± standard deviation. Comparisons between groups were made by analysis of variance (ANOVA), and when significant, were examined by Tukey's all-pairwise-comparison test. Differences were considered significant when P < 0.05. Statistical analysis was performed using Excel 2004 (Microsoft, Redmond, WA, USA) with the add-in software Statcal 2 (Yanai, 2004) .
RESULTS
Effect of EGCG on differentiation of MC3T3-E1 cells
MC3T3-E1 cells originally derived from mouse calvaria were used to investigate the physiological role of EGCG on the differentiation of osteoblasts (Kodama et al., 1981) . MC3T3-E1 cells were cultured in a medium containing the green tea catechin EGCG, ECG, red grape polyphenol resveratrol, or N-acetylcysteine for 10 d. The dyeing analysis of the ALP-positive cells by the ALP stain method revealed that the number of ALP-positive cells decreased by the stimulation of 10 µM EGCG and 10 µM ECG (Fig. 1A) . On the other hand, there was almost no change in the cells treated with 10 µM resveratrol. The ALP activity was reduced by the addition of EGCG and ECG, whereas resveratrol did not affect ALP activity ( Fig. 1B (a) ). Furthermore, 10 mM N-acetylcysteine, which has anti-oxidant activity, increased ALP activity (Fig. 1B (b) ).
Next, MC3T3-E1 cells were cultured in the presence of EGCG (0, 1, 2.5, 5, or 10 µM) for 4 d, 7 d, and 10 d, and the ALP activity was measured. As shown in Figure 2A , EGCG reduced the ALP activity dose-dependently: 10 µM EGCG suppressed ALP activity to about 50% of the control. The influence of EGCG on the expression of osteoblast-specific gene was analyzed by RT-PCR. Both expressions of ALP and OCN decreased as a result of the addition of EGCG (Fig. 2B) . These results revealed that tea catechin, especially EGCG, suppressed the differentiation of MC3T3-E1 cells.
EGCG does not change the viability and proliferation of MC3T3-E1 cells
Next, the effects of catechin (EGCG) on the viability or proliferation of MC3T3-E1 cells were analyzed. First, the dead cells were dyed by trypan blue. Although trypan blue dyed most of the cells that had been treated by 100 mM H 2 O 2 , the trypan blue-positive cells were hardly detected under the treatment by 10 µM EGCG (Fig. 3A) . 
Effect of EGCG on physiological function of differentiated MC3T3-E1 cells
Next, the physiological function of EGCG on differentiated osteoblasts was analyzed. MC3T3-E1 cells were cultured for 10 d to induce differentiation, then the differentiated cells were cultured for a further 10 d with EGCG (0, 1, 2.5, 5, or 10 µM).
ALP analysis revealed that EGCG treatment had no effect on ALP activity in the differentiated cells at all (Fig. 4A) . Next, the effect of EGCG on mineralization by osteoblasts was analyzed. The MC3T3-E1 cells cultured for 10 d were incubated for a further 10 d with 10 mM β-glycerophosphate and 10 µM EGCG to induce mineralization. Analysis by the Alizarine Red S stain method clarified that EGCG had no effect at all on mineralization in the differentiated MC3T3-E1 cells (Fig. 4B ). These data do not contradict the result that EGCG had no influence on the cell proliferation and survival rate of MC3T3-E1 cells. The results suggested that EGCG did not affect ALP activity or mineralization in the differentiated osteoblasts.
Effect of EGCG on osteoclast formation in co-cultured cells
It is well known that osteoblasts induce the differentiation of osteoclasts through the production of RANKL and CSF-1 (Katagiri and Takahashi, 2002) . Therefore, the influence of EGCG on the ability of osteoblasts to induce differentiation was analyzed by using co-culture of osteoblasts and the precursor of osteoclasts. The osteoblasts collected from the calvaria of mouse newborn and bone marrow cells collected from mouse tibia and femur were cultured simultaneously on the same plate under the stimulation of 1, 25(OH) 2 D 3 to stimulate the differentiation of osteoclasts. The expression of TRAP is specific to osteoclasts. The dyeing analysis of the TRAP-positive cells by the TRAP-stain method was performed. The number of differentiated osteoclasts decreased by the treatment of 10 µM EGCG (Fig. 5A) , and EGCG suppressed the formation of osteoclasts from the bone marrow cells cultured solely in the presence of RANKL and CSF-1 (Fig. 5A) . So, we analyzed whether EGCG affects the induction of osteoclast differentiation through the action of osteoblasts. RT-PCR analysis of RANKL and CSF-1 in osteoblasts revealed that EGCG did not change the expression of RANKL or CSF-1 (Fig. 5B ). In addition, RAW264 cells were cultured in the medium containing EGCG (0, 1, 2.5, 5, or 10 µM) and 100 ng/mL RANKL for 5 d. EGCG remarkably suppressed the formation of osteoclasts from RAW264 cells, too (Fig. 6A) , and the number of osteoclasts was decreased by EGCG treatment (Fig. 6B) . These results suggested that EGCG suppressed the development of osteoclasts in co-cultured cells, possibly through direct action on osteoclast precursor cells.
DISCUSSION
It has been reported some polyphenols have physiological actions on the regulation of bone metabolism. For example, red wine polyphenols, such as resveratrol and piceatannol, promoted the differentiation of osteoblasts and so on (Mizutani et al., 1998; Chang et al., 2006) , and resveratrol and EGCG led to the cell death of osteoclasts (Nakagawa et al., 2002; Boissy et al., 2005; Yun et al., 2007) . It is well known that these physiological actions are caused partially by the anti-oxidative effect of polyphenol, however, the molecular mechanism of these effects is not well understood.
Therefore, we analyzed the physiological effects of EGCG on the differentiation of osteoblasts by using a precursor cell line of osteoblasts, MC3T3-E1, which was originally derived from mouse calvaria (Kodama et al., 1981) . ALP activation decreased remarkably when tea catechin EGCG or ECG was added to the culture of MC3T3-E1 (Fig. 1) . EGCG suppressed the expression of mRNA of ALP and OCN which are specifically expressed in osteoblasts (Fig. 2B) . On the other hand, because resveratrol did not reduce ALP activity at all (Fig. 1) , it is suggested that osteoblast differentiation is suppressed by tea catechin specifically. Moreover, the anti-oxidant N-acetylcysteine increased ALP activity (Fig. 1B (b) ). It was also reported that N-acetylcysteine promotes the differentiation of osteoblasts (Jun et al., 2008) , and therefore EGCG may be involved in osteoblast differentiation by a mechanism other than its anti-oxidative action. Recently, Tachibana et al. (2004) reported that EGCG acted on the specific signaling pathway through binding to the 67 kDa laminin receptor. The signaling pathway of 67LR is known little, however, it is thought that extracellular signal-regulated kinase and myosin regulatory light chain possibly be involved in (Fujiwara et al., 2005; Umeda et al., 2005) . Therefore, further investigation is necessary to analyze whether this laminin receptor is actually involved in the signal transduction of EGCG in osteoblasts. EGCG influenced neither the cell death of MC3T3-E1 nor cell survival rate (Figs. 3A, B) . Since EGCG affected cell proliferation much less (Fig. 3C) , it is possible that EGCG influences the differentiation of osteoblasts directly.
Next, the effect of EGCG on the bone formation of osteoblasts was analyzed to clarify the role of EGCG in the function of osteoblasts. As a result, EGCG had no effect on ALP activity in the differentiated MC3T3-E1 cell (Fig. 4A ). This result suggests that EGCG did not affect the enzymatic activity of ALP itself, either. Furthermore, the addition of EGCG to the differentiated MC3T3-E1 cell did not influence mineralization (Fig. 4B) . These results suggest that EGCG has a suppressive effect on differentiation to the precursor cell of osteoblasts, although EGCG has little effect on differentiated osteoblasts. The osteoblasts lead to the differentiation of osteoclasts through the production of RANKL. The formation of osteoclasts was decreased by the addition of EGCG when the osteoblasts from the mouse calvaria and the mouse bone marrow cell were co-cultured (Fig. 5A ). When EGCG was added to the single-culture of bone marrow cells, the number of osteoclasts decreased (Fig. 5A ) and the mRNA expression of RANKL and CSF-1 was not changed (Fig. 5B) , so it is possible that EGCG acts on the precursor of osteoclasts directly, resulting in the suppression of differentiation. In order to know the direct action of EGCG on osteoclast development, mouse RAW264, an osteoclast differentiation-inducible cell line, was used for analysis. The mouse RAW264, a macrophage-like monocyte cell line, can develop into osteoclast-like multi-nuclear cells under the stimulation of RANKL (Matsumoto et al., 2000; Ralph and Nakoinz, 1977) . EGCG suppressed the osteoclast formation of RAW264 cells, too (Fig. 6 ). There are also reports that EGCG promotes the cell death of osteoclast cell lines (Nakagawa et al., 2002; Yun et al., 2007) , suggesting that EGCG may promote cell death of osteoclasts or their precursor directly, thus reducing the number of osteoclasts.
Judging from the previous data (Nakagawa et al., 2002; Yun et al., 2007) , EGCG possibly acts on osteoclasts or their precursor cell directly, and suppresses the differentiation of osteoclasts. Furthermore, because EGCG suppressed the differentiation of osteoblasts, it is thought that EGCG restrains the number of osteoclasts by suppressing the new formation of osteoblasts, in vivo. Of course, the concentration of EGCG in the blood is critically important to know the physiological role of EGCG in living animals. So far, it has been reported that the concentration of EGCG rises to about 10 µM in the blood when a high dose EGCG is administered orally (Ullmann et al., 2003) . In this study, we applied less than 10 µM of EGCG, suggesting a condition which is close to that of the living body. This indicates that EGCG can be used as an effective medicine against the symptoms of osteoporosis. 
